E-LIB Suche - Ergebnisse für: Vaishampayan, Ulka

1

Development of an orally bioavailable mSWI/SNF ATPase degra..:

He, Tongchen ; Cheng, Caleb ; Qiao, Yuanyuan...
Proceedings of the National Academy of Sciences. 121 (2024) 15 - p. , 2024

Link: https://doi.org/10.1073/..

2

A phase Ib study evaluating the recommended phase II dose, ..:

Juric, Dejan ; Barve, Minal ; Vaishampayan, Ulka...
Cancer Medicine. 13 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

3

Characterization of Responses to Lenvatinib plus Pembrolizu..:

Motzer, Robert J. ; Choueiri, Toni K. ; Hutson, Thomas...
European Urology. 86 (2024) 1 - p. 4-9 , 2024

Link: https://doi.org/10.1016/..

4

SWOG S1931 (PROBE): PHASE III RANDOMIZED TRIAL OF IMMUNE CH..:

Kim, Hyung ; Tangen, Catherine M. ; Vaishampayan, Ulka...
Urologic Oncology: Seminars and Original Investigations. 42 (2024) - p. S4 , 2024

Link: https://doi.org/10.1016/..

5

Prevalence of Dietary Modification and Supplement Use in Pa..:

Ebrahimi, Hedyeh ; Battle, Dena ; Salgia, Nicholas J....
Nutrients. 16 (2024) 11 - p. 1630 , 2024

Link: https://doi.org/10.3390/..

6

Phase 1/2 study of PRO1160, a CD70-directed antibody-drug c..:

Jonasch, Eric ; Call, Justin ; Kambhampati, Swetha...
The Oncologist. 28 (2023) Supplement_1 - p. S14-S15 , 2023

Link: https://doi.org/10.1093/..

7

Metastatic renal cell carcinoma to the pancreas and other s..:

Duarte, Cassandra ; Hu, Junxiao ; Beuselinck, Benoit...
eClinicalMedicine. 60 (2023) - p. 102018 , 2023

Link: https://doi.org/10.1016/..

8

Radiogenomic Associations Clear Cell Renal Cell Carcinoma: ..:

Liu, Derek H ; Dani, Komal A ; Reddy, Sharath S...
Oncology. 101 (2023) 6 - p. 375-388 , 2023

Link: https://doi.org/10.1159/..

9

Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prost..:

Govindarajan, Barani ; Sbrissa, Diego ; Pressprich, Mark...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

10

Current Landscape of Genomic Biomarkers in Clear Cell Renal..:

Cotta, Brittney H. ; Choueiri, Toni K. ; Cieslik, Marcin...
European Urology. 84 (2023) 2 - p. 166-175 , 2023

Link: https://doi.org/10.1016/..

11

Lessons from 801 clinical TFE3/TFEB fluorescence in situ hy..:

Wang, Xiao-Ming ; Shao, Lina ; Xiao, Hong...
American Journal of Clinical Pathology. 160 (2023) 6 - p. 549-554 , 2023

Link: https://doi.org/10.1093/..

12

Analysis of the Tumor Immune Microenvironment (TIME) in Cle..:

Farha, Mark ; Nallandhighal, Srinivas ; Vince, Randy...
Cancers. 15 (2023) 23 - p. 5530 , 2023

Link: https://doi.org/10.3390/..

13

Circulating and intratumoral immune determinants of respons..:

Saliby, Renee Maria ; El Zarif, Talal ; Bakouny, Ziad...
The Oncologist. 28 (2023) Supplement_1 - p. S15-S16 , 2023

Link: https://doi.org/10.1093/..

14

Predictive biomarkers for survival benefit with ramucirumab..:

van der Heijden, Michiel S. ; Powles, Thomas ; Petrylak, Daniel...
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

15

Clinical outcomes of ovarian cancer patients treated with t..:

Winer, Ira ; Vaishampayan, Ulka ; Gilbert, Lucy...
Gynecologic Oncology. 166 (2022) - p. S49 , 2022

Link: https://doi.org/10.1016/..